iShares Genomics Immunology and Healthcare ETF
IDNA----
Portfolio
Oct 30, 2026- Stock99.79%
- Cash0.21%
Morningstar style box
Oct 30, 2026Current style: Mid Blend
Large
Mid
Small
13%
18%
0%
7%
26%
1%
7%
19%
10%
ValueBlendGrowth
Weight %50+25-4910-240-9
Top Holdings
Oct 30, 2026Top 10 Holdings Weight: 51.1%
| Name/code | Weight | Type | Industry | Style | Price | Change % | Market Cap |
|---|---|---|---|---|---|---|---|
| 12.82% | Equity | Health Care | Large Blend | — | — | — | |
2  Genmab AS | 6.51% | — | — | — | — | — | — |
| 6.06% | Equity | Health Care | Mid Blend | — | — | — | |
| 4.01% | Equity | Health Care | Large Blend | — | — | — | |
5 Takeda Pharmaceutical Co Ltd | 3.77% | — | — | — | — | — | — |
| 3.71% | Equity | Health Care | Large Value | — | — | — | |
| 3.62% | Equity | Health Care | Mid Growth | — | — | — | |
| 3.61% | Equity | Health Care | Mid Blend | — | — | — | |
| 3.52% | Equity | Health Care | Mid Blend | — | — | — | |
| 3.43% | Equity | Health Care | Large Blend | — | — | — |
